Navigation Links
Avantium Appoints Jonathan Wolfson to its Supervisory Board
Date:1/31/2013

AMSTERDAM, January 31, 2013 /PRNewswire/ --

Avantium announced the appointment of Jonathan Wolfson to its Supervisory Board. Jonathan Wolfson is Chief Executive Officer and co-founder of Solazyme. Solazyme is a leading industrial biotechnology company producing renewable oil and bioproducts from microalgae for fuels, chemicals, nutrition and personal care products. Solazyme (SZYM) is a US stock listed company at NASDAQ. Mr. Wolfson and Solazyme have received numerous awards for their technology pioneering role in the industrial biotechnology industry. Mr. Wolfson holds J.D. and M.B.A. degrees from the NYU School of Law and the NYU Stern School of Business

Jonathan Wolfson said on his appointment:"I am very happy to join the Supervisory Board at Avantium.  I have known the Company for years and have been increasingly impressed with its world class catalytic technology and the incredibly exciting development of the YXY technology platform.  I look forward to working with the company as it brings its disruptive biobased plastics and chemicals to market."

"We are proud to have Jonathan Wolfson appointed to our Supervisory Board", says Tom van Aken , CEO of Avantium. "Jonathan has played a major role in the successful development of Solazyme, its successful IPO and the formation of strategic partnerships in the food, cosmetics and fuels industries. His experience and insights in bringing biobased chemicals to the market, will be very valuable for Avantium to commercialize its YXY technology for the production and use of FDCA and PEF."

About Avantium

Avantium is a game-changing renewable chemicals company with leadership in advanced catalysis R&D. It developed the breakthrough YXY technology, a proprietary process to convert carbohydrates into the green building blocks FDCA for making biobased plastics and biobased chemicals at cost competitive prices in large markets. Avantium's lead application PEF (polyethylene furanoate) fulfils key criteria to become the next generation biobased plastics for bottles, film and fibers. Avantium has demonstrated the value and commercial potential of its unique technology by collaborating with leading companies like The Coca-Cola Company and Danone for the development of 100% biobased PEF bottles. Avantium plans to have the first commercial scale manufacturing plant operational by 2016. Avantium laboratories and headquarters are based in Amsterdam, the Netherlands.


'/>"/>
SOURCE Avantium
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. Elsevier / MEDai Appoints Tom Zajac as New President
3. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
4. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
5. BioStorage Technologies Appoints New Member to Board of Directors
6. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
7. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
8. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
9. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
10. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
11. Veracyte Appoints Mark Spring as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... Conn. , Jan. 12, 2017   ... company and maker of Flublok Influenza Vaccine ... Zika vaccine candidate had good safety results and ... in preclinical studies. The product is expected to ... few months.  In addition, the Institute of Technology ...
(Date:1/12/2017)... -- The report "Direct-Fed Microbials Market by Type (Lactic Acid Bacteria and Bacillus), ... - Global Forecast to 2022", published by MarketsandMarkets, the global market is estimated ... USD 1,399.6 Million by 2022, at a CAGR of 6.96% from 2016. ... ... MarketsandMarkets Logo ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical ... promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. ... Twenty-seven percent of these heavily pretreated patients saw clinical benefit from the drug, ...
(Date:1/11/2017)... ... 11, 2017 , ... As a graduate student, Scarlet Shell ... that cause malaria and tuberculosis. Seeing firsthand the ravages those diseases visit on ... an assistant professor of biology and biotechnology at Worcester Polytechnic Institute (WPI), Shell ...
Breaking Biology Technology:
(Date:1/3/2017)... -- Onitor, provider of digital health technology for consumers, ... biometric data-driven program designed to aid weight loss for ... Consumer Electronics Show (CES) in Las Vegas ... World Health Organization (WHO), have identified lifestyle risks that ... overweight or obese. WHO also states that more people ...
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
(Date:12/16/2016)... , Dec. 16, 2016   IdentyTechSolutions America ... management products and solutions and a cutting-edge manufacturer ... that it is offering seamless, integrated solutions that ... entrance products. The solutions provide IdentyTech,s customers with ... their facilities from crime and theft. ...
Breaking Biology News(10 mins):